At the completion of this activity, the participant will be able to:
1. Review CDK4/6 inhibitors mechanism of action and relevant side effects
2. Recommend an appropriate CDK4/6 inhibitor based on stage of breast cancer.
3. Analyze unique adverse effect profiles associated with CDK4/6 agents and how this will influence monitoring parameters
4. Select a CDK4/6 agent based on patient specific factors

Session date: 
10/20/2023 - 12:00pm to 1:00pm EDT
Location: 
WPH Auditorium
WPH Conference Center
Zoom Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454 - Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.